GMS reported quarterly earnings of $1.29 per share, beating the forecast of $1.15. However, this is a drop from last year’s $1.93 per share. This quarter, GMS had an earnings surprise of 12.17%, recovering from a significant miss of -33.81% the previous quarter. In the last year, GMS has only exceeded earnings estimates once out of four quarters. For the quarter ending April 2025, GMS posted revenues of $1.33 billion, which is 2.81% above estimates. Still, this is lower than last year’s $1.41 billion. Over the past year, the company has beaten revenue estimates just twice. Since the beginning of the year, GMS shares are down about 13.7%, while the S&P 500 has gained 1.7%. Future stock performance will depend heavily on insights from management during the earnings call. Meanwhile, Walgreens Boots Alliance is expected to report earnings of $0.34 per share, reflecting a 46% year-over-year decline. Their estimated revenues are $36.66 billion, showing a small increase of 0.9% compared to last year. The expected earnings per share (EPS) and revenues for the next quarter are $1.65 and $1.42 billion, respectively. GMS’s recent earnings of $1.29 per share exceeded Wall Street’s expectations of $1.15, but still fell short of last year’s figures. This performance is a modest surprise but not a full recovery. The 12.17% beat comes after a nearly 34% miss in the previous quarter. Revenue for the quarter was $1.33 billion, 2.81% higher than estimates but down from last year’s $1.41 billion, showing ongoing pressure on revenue. In the past four quarters, GMS has only exceeded revenue expectations twice and EPS estimates once, highlighting a lack of consistency. From a market view, GMS shares have underperformed, dropping 13.7% since January while the S&P 500 has increased by 1.7%. Such differences in performance are notable and can signal momentum changes or valuation adjustments. The stock’s near-term direction will rely less on the numbers themselves and more on management’s comments after the earnings release. If guidance is optimistic regarding cost control and margin improvement, sentiment may improve. However, vague or cautious management language can lead to further declines. Attention also turns to Walgreens Boots Alliance, which is set to report soon. Expected earnings are $0.34 per share, a 46% drop from a year ago. Nevertheless, the revenue forecast of $36.66 billion indicates a slight year-over-year growth of 0.9%, although this may be overshadowed by cost pressures. Looking ahead, EPS estimates for the next quarter are more hopeful at $1.65, with revenues at $1.42 billion. This suggests some anticipated recovery, but its validity depends on margins, operational efficiency, and the strength of consumer spending in the coming months. It’s essential to consider past performance trends, but they shouldn’t solely dictate future direction. Earnings releases should be seen as checkpoints. While surprises matter, understanding how the business is evolving—through cost management, pricing strategies, and capital allocation—is crucial. As we monitor sector data, the mismatch between declining earnings and stable revenue can indicate rising input costs or pricing pressure. If adjustments are needed, they typically happen quickly, leading to increased volatility across related stocks. So, it’s important to stay nimble around earnings reports. We recommend reviewing implied volatility levels for upcoming expirations. Between GMS and Walgreens, there could be unexpected price movements based on forward guidance or market adjustments to revised yearly outlooks. Remaining flexible in positioning is key until clear catalysts emerge.

here to set up a live account on VT Markets now